Table 1 Transitional cell carcinoma of the bladder incidence and incidence-based mortality rates (1973–2014)
characteristic | Incidence of bladder cancer | Incidence-based mortality of bladder cancer | ||
|---|---|---|---|---|
Cases, No (%)a | Rate (95% CI)b | Deaths, No (%)a | Rate (95% CI)b | |
Overall | 182,114 (100) | 26.43 (26.55–26.31) | 123,137(100) | 18.68 (18.57–18.78) |
Sex | ||||
 Male | 136,897 (75.1) | 47.21 (46.95–47.46) | 92,733 (75.3) | 37.70 (37.45–37.95) |
 Female | 45,217 (24.8) | 11.48 (11.38–11.59) | 30,404 (24.6) | 7.41 (7.33–7.50) |
Race | ||||
 Caucasian | 166,426 (91.3) | 28.77 (28.63–28.91) | 113,599 (92.2) | 20.13 (20.02–20.25) |
 African American | 7939 (4.3) | 15.07 (14.73–15.41) | 5493 (4.4) | 11.92 (11.60–12.25) |
 Othersc | 6798 (3.7) | 12.04 (11.75–12.34) | 3866 (3.1) | 7.72 (7.48–7.97) |
Age at diagnosis, y | ||||
 20–44 | 5527 (3.0) | 1.57 (1.53–1.62) | 353 (0.4) | 0.10 (0.09–0.12) |
 45–64 | 50,194 (27.5) | 21.01 (20.83–21.2) | 10,369 (8.42) | 4.25 (4.17–4.33) |
 65–84 | 107,382 (58.9) | 103.89 (103.27–104.51) | 70,946 (57.6) | 70.2 (69.68–70.72) |
  > 84 | 19,011 (10.4) | 134.61 (132.7–136.53) | 41,469 (33.6) | 293.62 (290.8–296.46) |
State | ||||
 California | 26,322 (14.4) | 24.07 (23.78–24.37) | 18,017 (14.6) | 17.21 (16.96–17.47) |
 Connecticut | 33,844 (18.5) | 32.3 (31.95–32.64) | 22,862 (18.5) | 21.99 (21.71–22.28) |
 Georgia | 10,954 (6) | 22.29 (21.86–22.72) | 6824 (5.5) | 16.16 (15.77–16.55) |
 Hawaii | 5744 (3.2) | 17.85 (17.39–18.32) | 3650 (2.9) | 11.99 (11.61–12.39) |
 Iowa | 26,254 (14.4) | 26.95 (26.62–27.28) | 18,888 (15.3) | 18.34 (18.08–18.61) |
 Michigan | 33,036 (18.1) | 29.51 (29.19–29.83) | 22,985 (18.6) | 21.98 (21.7–22.27) |
 New Mexico | 8838 (4.9) | 19.88 (19.47–20.31) | 5912 (4.8) | 14.63 (14.26–15.01) |
 Utah | 8769 (4.8) | 21.15 (20.71–21.60) | 5689 (4.6) | 15 (14.61–15.39) |
 Washington | 28,353 (15.5) | 29.13 (28.79–29.48) | 18,310 (14.8) | 19.95 (19.66–20.24) |
Stage at diagnosisd | ||||
 Localized | 139,766 (76.7) | 20.24 (20.14–20.35) | 87,384 (70.9) | 13.32 (13.24–13.41) |
 Regional | 31,612 (17.3) | 4.62 (4.57–4.67) | 26,214 (21.2) | 3.93 (3.89–3.98) |
 Distant | 5174 (2.8) | 0.75 (0.73–0 .77) | 4922 (3.9) | 0.72 (0.70–0.74) |
Site | ||||
 Trigone | 10,849 (5.8) | 1.57 (1.54–1.60) | 7030 (5.7) | 1.07 (1.04–1.09) |
 Dome | 6176 (3.4) | 0.91 (0.88–0.93) | 4495 (3.7) | 0.68 (0.66–0.70) |
 Lateral wall | 37,061 (20.4) | 5.35 (5.29–5.40) | 23,266 (18.9) | 3.53 (3.49–3.58) |
 Anterior wall | 3112 (1.7) | 0.46 (0.44–0.47) | 2155 (1.8) | 0.33 (0.31–0.34) |
 Posterior wall | 14,482 (8) | 2.11 (2.08–2.15) | 9199 (7.5) | 1.40 (1.37–1.43) |
 Neck | 5478 (3.1) | 0.8 (0.78–0.82) | 3868 (3.1) | 0.59 (0.57–0.61) |
 Ureteric orifice | 9709 (5.3) | 1.39 (1.36–1.42) | 6451 (5.2) | 0.98 (0.96–1) |
 Urachus | 27 (0.01) | 0.004 (0.003–0.006) | 19 (0.01) | 0.003 (0.002–0.005) |
 Overlapping lesions | 19,999 (11) | 2.91 (2.87–2.96) | 15,138 (12.3) | 2.29 (2.25–2.32) |
 Unknown | 75,221 (41.3) | 10.92 (10.84–11) | 51,516 (41.8) | 7.81 (7.74–7.88) |